E
Elligo Health Research
Direct access to over 150 million known patients and their healthcare data
At a glance
- Founded
- 2016
- Headquarters
- Austin, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- SCShumway Capital
Series B and later11 investors entered at this stage
- NPNoro-Moseley Partners
- PSPiper Sandler
- HPHatteras Venture Partners
- MCMorgan Stanley Expansion Capital
- PGPiper Jaffray Private Capital Group
Norwest Venture Partners- EVExcelerate Health Ventures
- AGAlly Bridge Group
- FHFS Healthcare
- CACerner (Formerly PGI & Associates)
- SHSyneos Health
Source: Dealroom Talent Intelligence.
Global footprint
across markets
Investments and acquisitions
Disclosed deals where Elligo Health Research was the backer or acquirer, 2018–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
3 deals across Elligo Health Research's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Elligo Health Research's portfolio, mapped.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Elligo Health Research on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Elligo Health Research on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.